Genmab AS (GMAB) — Net Asset Quality Index
Genmab AS (GMAB) has a Net Asset Quality Index of 45.4% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $12.84 Billion minus total liabilities of $7.01 Billion yields net assets of $5.83 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Genmab AS (GMAB) total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Genmab AS Net Asset Quality Index Over Time (2002–2025)
This chart shows how Genmab AS's Net Asset Quality Index has evolved across 24 annual periods from 2002 to 2025. As of December 2025, the index stands at 45.4%, representing net assets of $5.83 Billion against total assets of $12.84 Billion USD. For live market cap and overall valuation, see GMAB market cap overview.
Annual Net Asset Quality Index for Genmab AS (2002–2025)
The table below presents the year-by-year Net Asset Quality Index for Genmab AS from 2002 to 2025, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check how strategically is Genmab AS's equity deployed to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 45.4% | $5.83 Billion | $12.84 Billion | $7.01 Billion | ▼ -34.7 pp |
| 2024 | 80.1% | $36.70 Billion | $45.81 Billion | $9.11 Billion | ▼ -9.5 pp |
| 2023 | 89.6% | $31.61 Billion | $35.29 Billion | $3.68 Billion | ▼ -1.0 pp |
| 2022 | 90.6% | $27.28 Billion | $30.12 Billion | $2.84 Billion | ▲ +0.5 pp |
| 2021 | 90.1% | $22.20 Billion | $24.63 Billion | $2.43 Billion | ▼ -0.3 pp |
| 2020 | 90.4% | $19.12 Billion | $21.14 Billion | $2.02 Billion | ▼ -2.3 pp |
| 2019 | 92.8% | $14.05 Billion | $15.14 Billion | $1.10 Billion | ▼ -2.0 pp |
| 2018 | 94.7% | $8.01 Billion | $8.46 Billion | $446.64 Million | ▼ -0.3 pp |
| 2017 | 95.0% | $6.27 Billion | $6.60 Billion | $330.75 Million | ▲ +2.8 pp |
| 2016 | 92.1% | $4.83 Billion | $5.24 Billion | $411.54 Million | ▲ +2.8 pp |
| 2015 | 89.3% | $3.49 Billion | $3.90 Billion | $415.83 Million | ▲ +18.4 pp |
| 2014 | 70.9% | $2.03 Billion | $2.87 Billion | $833.74 Million | ▲ +32.8 pp |
| 2013 | 38.1% | $659.52 Million | $1.73 Billion | $1.07 Billion | ▲ +15.5 pp |
| 2012 | 22.6% | $383.19 Million | $1.69 Billion | $1.31 Billion | ▼ -8.5 pp |
| 2011 | 31.1% | $486.42 Million | $1.56 Billion | $1.08 Billion | ▼ -12.4 pp |
| 2010 | 43.5% | $1.08 Billion | $2.48 Billion | $1.40 Billion | ▼ -14.9 pp |
| 2009 | 58.4% | $1.30 Billion | $2.22 Billion | $924.34 Million | ▼ -8.8 pp |
| 2008 | 67.2% | $2.19 Billion | $3.26 Billion | $1.07 Billion | ▼ -5.7 pp |
| 2007 | 72.8% | $2.88 Billion | $3.96 Billion | $1.08 Billion | ▼ -16.2 pp |
| 2006 | 89.1% | $1.61 Billion | $1.80 Billion | $197.05 Million | ▲ +7.4 pp |
| 2005 | 81.6% | $1.12 Billion | $1.37 Billion | $251.66 Million | ▼ -11.2 pp |
| 2004 | 92.9% | $1.18 Billion | $1.27 Billion | $90.92 Million | ▲ +0.8 pp |
| 2003 | 92.1% | $1.09 Billion | $1.18 Billion | $93.67 Million | ▲ +3.7 pp |
| 2002 | 88.4% | $1.40 Billion | $1.58 Billion | $183.97 Million | — |